Treatment of axillary hyperpigmentation. Disorder of pigmentation, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults between 18 and 65 years old Complying with study protocols and signing informed consent voluntarily Enthusiastic people and having the right cooperation for the next follow-up People with a diagnosis of axillary hyperpigmentation confirmed by a dermatologist (the skin of the axillary area has a color difference of at least 2 degrees with the skin of the surrounding area)
Exclusion criteria
Exclusion criteria: Pregnancy and breastfeeding Acanthosis nigricans Body mass index above 27 skin diseases with abnormal hyperpigmentation such as Riehl melanosis and lichen planus pigmentosa Patients undergoing chemotherapy treatment Patients treated with antiretroviral drugs Patients with shoulder pain or stiffness in the shoulder area for whom it is difficult to tolerate laser treatment Use of local treatments during the last 1 month Use of laser treatments in the past 2 months at the site Patients with active bacterial or viral infection in the treatment area History of skin cancers uncontrolled systemic disease Photosensitivity Seizure history History of hypertrophic and keloid scars
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Illumination of the treated area. Timepoint: In addition to the basic visit, before each laser session (every 3 weeks), patients are also clinically evaluated 1 month after the last laser session. Method of measurement: Based on Von Luschan's chromatic classification criterion and its improvement rate is based on Luminosity difference between axilla and periaxilla in each session and comparing this score between sessions. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences